Effects of Adiponectin on T2DM and Glucose Homeostasis: A Mendelian Randomization Study

References

• Miguel-Escalada I, Bonàs-Guarch S, Cebola I, et al. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nat Genet. 2019;51(7):1137–1148. doi:10.1038/s41588-019-0457-0
   PubMedGoogle Scholar
• Long T, Wang J, Han X, et al. Association between resting heart rate and incident diabetes risk: a Mendelian randomization study. Acta Diabetol. 2019;56:1037–1044. doi:10.1007/s00592-019-01344-3
   PubMed Web of Science ®Google Scholar
• Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (London, England). 2016;387(10027):1513–1530. doi:10.1016/S0140-6736(16)00618-8
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–959. doi:10.1001/jama.2013.168118
   PubMed Web of Science ®Google Scholar
• Li J, Ni J, Wu Y, et al. Sex differences in the prevalence, awareness, treatment, and control of diabetes mellitus among adults aged 45 years and older in rural areas of Northern China: a cross-sectional, population-based study. Front Endocrinol (Lausanne). 2019;10:147. doi:10.3389/fendo.2019.00147
   PubMedGoogle Scholar
• Juma PA, Mohamed SF, Matanje Mwagomba BL, et al. Non-communicable disease prevention policy process in five African countries authors. BMC Public Health. 2018;18(Suppl 1):961. doi:10.1186/s12889-018-5825-7
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in Patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71:793–801. doi:10.1016/j.jhep.2019.06.021
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Willemsen G, Ward KJ, Bell CG, et al. The concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin registers: the discordant twin (DISCOTWIN) consortium. Twin Res Hum Genet. 2015;18(6):762–771. doi:10.1017/thg.2015.83
   PubMed Web of Science ®Google Scholar
• Dastani Z, Hivert MF, Timpson N, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8(3):e1002607.
   PubMed Web of Science ®Google Scholar
• Yeung SLA, Schooling CM. Adiponectin and coronary artery disease risk: a bi-directional Mendelian randomization study. Int J Cardiol. 2018;268:222–226. doi:10.1016/j.ijcard.2018.03.132
   PubMedGoogle Scholar
• Jee SH, Sull JW, Lee J-E, et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet. 2010;87(4):545–552. doi:10.1016/j.ajhg.2010.09.004
   PubMedGoogle Scholar
• Wu Y, Li Y, Lange EM, et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet. 2010;19(24):4955–4964. doi:10.1093/hmg/ddq423
   PubMedGoogle Scholar
• Chung C-M, Lin T-H, Chen J-W, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011;60(9):2417–2423. doi:10.2337/db10-1321
   PubMedGoogle Scholar
• Wu Y, Gao H, Li H, et al. A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. Hum Mol Genet. 2014;23(4):1108–1119. doi:10.1093/hmg/ddt488
   PubMedGoogle Scholar
• Dastani Z, Johnson T, Kronenberg F, et al. The shared allelic architecture of adiponectin levels and coronary artery disease. Atherosclerosis. 2013;229(1):145–148. doi:10.1016/j.atherosclerosis.2013.03.034
   PubMedGoogle Scholar
• Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007;13(3):332–339. doi:10.1038/nm1557
   PubMed Web of Science ®Google Scholar
• Borges MC, Oliveira IO, Freitas DF, et al. Obesity-induced hypoadiponectinaemia: the opposite influences of central and peripheral fat compartments. Int J Epidemiol. 2017;46(6):2044–2055. doi:10.1093/ije/dyx022
   PubMed Web of Science ®Google Scholar
• Zhuang H, Han J, Cheng L, Liu SL. A positive causal influence of IL-18 levels on the risk of T2DM: a mendelian randomization study. Front Genet. 2019;10:295. doi:10.3389/fgene.2019.00295
   PubMed Web of Science ®Google Scholar
• Swerdlow DI. Mendelian randomization and type 2 diabetes. Cardiovasc Drugs Ther. 2016;30(1):51–57. doi:10.1007/s10557-016-6638-5
   PubMed Web of Science ®Google Scholar
• Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–116. doi:10.1038/ng.520
   PubMed Web of Science ®Google Scholar
• Weber KS, Strassburger K, Pacini G, et al. Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetes. Diabet Med. 2017;34(2):239–244. doi:10.1111/dme.13278
   PubMedGoogle Scholar
• Mente A, Meyre D, Lanktree MB, et al. Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population. PLoS One. 2013;8(6):e66808. doi:10.1371/journal.pone.0066808
   PubMedGoogle Scholar
• Kashiwagi R, Yamada Y, Ito Y, et al. Increase in adiponectin level prevents the development of type 2 diabetes in Japanese men with low adiponectin levels. J Endocr Soc. 2018;2(7):753–764. doi:10.1210/js.2018-00033
   PubMedGoogle Scholar
• White J, Swerdlow DI, Preiss D, et al. Association of lipid fractions with risks for coronary artery disease and diabetes. JAMA Cardiol. 2016;1(6):692–699. doi:10.1001/jamacardio.2016.1884
   PubMed Web of Science ®Google Scholar
• Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet (London, England). 2010;375(9716):735–742. doi:10.1016/S0140-6736(09)61965-6
   PubMed Web of Science ®Google Scholar
• Fall T, Xie W, Poon W, et al. Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes. Diabetes. 2015;64(7):2676–2684. doi:10.2337/db14-1710
   PubMedGoogle Scholar
• Warren LL, Li L, Nelson MR, et al. Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation. Diabetes. 2012;61(5):1297–1301. doi:10.2337/db11-0985
   PubMedGoogle Scholar
• Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–314. doi:10.1002/gepi.21965
   PubMed Web of Science ®Google Scholar
• Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7. doi:10.7554/eLife.34408
   PubMed Web of Science ®Google Scholar
• Ortega Moreno L, Copetti M, Fontana A, et al. Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes. Cardiovasc Diabetol. 2016;15:17. doi:10.1186/s12933-016-0339-z
   PubMedGoogle Scholar
• Hartwig FP, Davies NM, Hemani G, Davey Smith G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;45(6):1717–1726. doi:10.1093/ije/dyx028
   PubMed Web of Science ®Google Scholar
• Ahmad OS, Morris JA, Mujammami M, et al. A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat Commun. 2015;6:7060. doi:10.1038/ncomms8060
   PubMedGoogle Scholar
• Venkatrao M, Nagarathna R, Patil SS, et al. A composite of BMI and waist circumference may be a better obesity metric in Indians with high risk for type 2 diabetes: an analysis of NMB-2017, a nationwide cross-sectional study. Diabetes Res Clin Pract. 2020;161:108037. doi:10.1016/j.diabres.2020.108037
   PubMed Web of Science ®Google Scholar
• Bais S, Patel NJ. Role of adiponectin and its target receptors to control deposition of fat in obesity related disorders. J Obes Med. 2019;16.
   Google Scholar
• Lee S, Lacy ME, Jankowich M, Correa A, Wu W-C. Association between obesity phenotypes of insulin resistance and risk of type 2 diabetes in African Americans: the Jackson Heart Study. J Clin Transl Endocrinol. 2019;19:100210. doi:10.1016/j.jcte.2019.100210
   PubMedGoogle Scholar
• Elizalde-Barrera CI, Rubio-Guerra AF, Lozano-Nuevo JJ, Olvera-Gomez JL. Triglycerides and waist to height ratio are more accurate than visceral adiposity and body adiposity index to predict impaired fasting glucose. Diabetes Res Clin Pract. 2019;153:49–54. doi:10.1016/j.diabres.2019.05.019
   PubMedGoogle Scholar
• Davidsson L, Alkhabbaz E, Vijayan V, et al. Intermediate hyperglycaemia, insulin resistance and metabolic syndrome among obese Arab children (12-17 years old) in Kuwait. Prim Care Diabetes. 2020. doi:10.1016/j.pcd.2020.02.001
   Google Scholar
• Xue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941. doi:10.1038/s41467-018-04951-w
   PubMed Web of Science ®Google Scholar
• Shim H, Chasman DI, Smith JD, et al. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS One. 2015;10(4):e0120758. doi:10.1371/journal.pone.0120758
   PubMed Web of Science ®Google Scholar
• Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–1998. doi:10.1093/ije/dyx102
   PubMed Web of Science ®Google Scholar
• Bowden J, Del Greco MF, Minelli C, et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36(11):1783–1802. doi:10.1002/sim.7221
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi:10.1093/ije/dyv080
   PubMed Web of Science ®Google Scholar
• Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497–1501. doi:10.1093/ije/dyt179
   PubMed Web of Science ®Google Scholar
• Liu G, Ding M, Chiuve SE, et al. Plasma levels of fatty acid-binding protein 4, retinol-binding protein 4, high-molecular-weight adiponectin, and cardiovascular mortality among men with type 2 diabetes: a 22-year prospective study. Arterioscler Thromb Vasc Biol. 2016;36(11):2259–2267. doi:10.1161/ATVBAHA.116.308320
   PubMed Web of Science ®Google Scholar
• Antuna-Puente B, Boutet E, Vigouroux C, et al. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency. J Clin Endocrinol Metab. 2010;95(3):1463–1468. doi:10.1210/jc.2009-1824
   PubMed Web of Science ®Google Scholar
• Consitt LA, Saxena G, Schaefer M. Sex-dependent reductions in high molecular weight adiponectin during acute hyperinsulinemia are prevented with endurance training in older females. Clin Endocrinol (Oxf). 2018;88(5):673–682. doi:10.1111/cen.13563
   PubMedGoogle Scholar
• Lee JY, Yang JW, Han BG, Choi SO, Kim JS. Adiponectin for the treatment of diabetic nephropathy. Korean J Intern Med. 2019;34(3):480–491. doi:10.3904/kjim.2019.109
   PubMed Web of Science ®Google Scholar
• Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes. 2007;56(8):2174–2177. doi:10.2337/db07-0185
   PubMed Web of Science ®Google Scholar
• Pereira RI, Snell-Bergeon JK, Erickson C, et al. Adiponectin dysregulation and insulin resistance in type 1 diabetes. J Clin Endocrinol Metab. 2012;97(4):E642–E647. doi:10.1210/jc.2011-2542
   PubMedGoogle Scholar
• Yaghootkar H, Lamina C, Scott RA et al,. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes. 2013;62(10):3589–3598.
   PubMedGoogle Scholar
• Yaghootkar H, Lamina C, Scott RA, et al. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes. 2013;62(10):3589–3598. doi:10.2337/db13-0128
   PubMedGoogle Scholar
• Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28(1):30–42. doi:10.1097/EDE.0000000000000559
   PubMed Web of Science ®Google Scholar
• Borges MC, Barros AJD, Ferreira DLS, et al. Metabolic profiling of adiponectin levels in adults: mendelian randomization analysis. Circ Cardiovasc Genet. 2017;10:6. doi:10.1161/CIRCGENETICS.117.001837
   Google Scholar
• Luo Q, Wen Z, Li Y, et al. Assessment causality in associations between serum uric acid and risk of schizophrenia: a two-sample bidirectional mendelian randomization study. Clin Epidemiol. 2020;12:223–233.
   PubMed Web of Science ®Google Scholar